<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_AUc6ZNe">Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease A Randomized Clinical Trial</title>
				<funder ref="#_pS98Rum">
					<orgName type="full">University of Sydney International</orgName>
				</funder>
				<funder ref="#_h483rFK #_2gNrQxH">
					<orgName type="full">NHMRC</orgName>
				</funder>
				<funder ref="#_cJ6duEQ">
					<orgName type="full">National Heart Foundation of Australia</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100001030</idno>
				</funder>
				<funder ref="#_5bgZ8Ts #_7jWmQ4V #_6pwJuPZ">
					<orgName type="full">National Heart Foundation</orgName>
				</funder>
				<funder ref="#_bytgFHw">
					<orgName type="full">National Health and Medical Research Council</orgName>
					<orgName type="abbreviated">NHMRC</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100000925</idno>
				</funder>
				<funder ref="#_XJ35rh7 #_sWzYjDn">
					<orgName type="full">unknown</orgName>
				</funder>
				<funder>
					<orgName type="full">Sydney Medical Foundation Chapman Fellowship</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">Copyright 2015 American Medical Association. All rights reserved. Original Investigation (Reprinted) 1255 Copyright 2015 American Medical Association. All rights reserved. Downloaded from jamanetwork.com by University of Iowa user on 07/12/2025 Copyright 2015 American Medical Association. All rights reserved. Copyright 2015 American Medical Association. All rights reserved. Downloaded from jamanetwork.com by University of Iowa user on 07/12/2025 Copyright 2015 American Medical Association. All rights reserved. -7. Copyright 2015 American Medical Association. All rights reserved. Downloaded from jamanetwork.com by University of Iowa user on 07/12/2025 Copyright 2015 American Medical Association. All rights reserved. 1262 Copyright 2015 American Medical Association. All rights reserved. Downloaded from jamanetwork.com by University of Iowa user on 07/12/2025 Copyright 2015 American Medical Association. All rights reserved. Copyright 2015 American Medical Association. All rights reserved. Downloaded from jamanetwork.com by University of Iowa user on 07/12/2025</p>
				</availability>
				<date type="published" when="2016-03-08">March 8, 2016.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>MBBS</roleName><forename type="first">Clara</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
							<email>cchow@georgeinstitute.org.au</email>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Julie</forename><surname>Redfern</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Graham</forename><forename type="middle">S</forename><surname>Hillis</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD;</roleName><forename type="first">Jay</forename><surname>Thakkar</surname></persName>
						</author>
						<author>
							<persName><roleName>MBBS</roleName><forename type="first">Karla</forename><surname>Santo</surname></persName>
						</author>
						<author>
							<persName><roleName>MBBS</roleName><forename type="first">Maree</forename><forename type="middle">L</forename><surname>Hackett</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD;</roleName><forename type="first">Stephen</forename><surname>Jan</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Nicholas</forename><surname>Graves</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Laura</forename><surname>De Keizer</surname></persName>
						</author>
						<author>
							<persName><roleName>BSc (Nutr</roleName><forename type="first">Tony</forename><surname>Barry</surname></persName>
						</author>
						<author>
							<persName><roleName>BSc</roleName><forename type="first">Severine</forename><surname>Bompoint</surname></persName>
						</author>
						<author>
							<persName><roleName>BSc (Stats</roleName><forename type="first">Sandrine</forename><surname>Stepien</surname></persName>
						</author>
						<author>
							<persName><roleName>MBiostat</roleName><forename type="first">Robyn</forename><surname>Whittaker</surname></persName>
						</author>
						<author>
							<persName><roleName>MPH</roleName><forename type="first">Anthony</forename><surname>Rodgers</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Aravinda</forename><surname>Thiagalingam</surname></persName>
						</author>
						<author>
							<persName><roleName>Thakkar</roleName><surname>Chow</surname></persName>
						</author>
						<author>
							<persName><surname>Barry</surname></persName>
						</author>
						<author>
							<persName><roleName>Thakkar</roleName><surname>Hillis</surname></persName>
						</author>
						<author>
							<persName><surname>Santo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jan</forename><surname>Hackett</surname></persName>
						</author>
						<author>
							<persName><roleName>Bompoint, Stepien</roleName><surname>De Keizer</surname></persName>
						</author>
						<author>
							<persName><roleName>FRACP</roleName><forename type="first">Robert</forename><surname>Abraham</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Mikhail</forename><surname>Altman</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">William</forename><surname>Chik</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">James</forename><surname>Chong</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Mark</forename><surname>Cooper</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Lloyd</forename><surname>Davis</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">A</forename><forename type="middle">Robert</forename><surname>Denniss</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Eddy</forename><surname>Kizana</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Pramesh</forename><surname>Kovoor</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Mahidi</forename><surname>Mardini</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Andrew</forename><surname>Ong</surname></persName>
						</author>
						<author>
							<persName><roleName>FRACP</roleName><forename type="first">Paul</forename><surname>Russell</surname></persName>
						</author>
						<author>
							<persName><roleName>FRACP</roleName><forename type="first">David</forename><surname>Ross</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Norman</forename><surname>Sadick</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Gopal</forename><surname>Sivagangabalan</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Michael</forename><surname>Skinner</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">David</forename><surname>Tanous</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<note type="raw_affiliation">The George Institute for Global Health , Sydney Medical School , University of Sydney , Sydney , Australia (</note>
								<orgName type="department">Sydney Medical School</orgName>
								<orgName type="institution" key="instit1">The George Institute for Global Health</orgName>
								<orgName type="institution" key="instit2">University of Sydney</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<note type="raw_affiliation">Chow , Redfern) ; Westmead Hospital , Sydney , Australia</note>
								<orgName type="department" key="dep1">Chow</orgName>
								<orgName type="department" key="dep2">Redfern)</orgName>
								<orgName type="institution">Westmead Hospital</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">Thiagalingam) ; The George Institute for Global Health , University of Sydney , Sydney , Australia</note>
								<orgName type="department" key="dep1">Thiagalingam)</orgName>
								<orgName type="department" key="dep2">The George Institute for Global Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<note type="raw_affiliation">Rodgers) ; Royal Perth Hospital , Perth , Australia ( Hillis) ;</note>
								<orgName type="department">Hillis)</orgName>
								<orgName type="institution" key="instit1">Rodgers)</orgName>
								<orgName type="institution" key="instit2">Royal Perth Hospital</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<note type="raw_affiliation">University of Western Australia , Perth ( Hillis) ;</note>
								<orgName type="department">Hillis)</orgName>
								<orgName type="institution">University of Western Australia</orgName>
								<address>
									<settlement>Perth</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<note type="raw_affiliation">Queensland University of Technology , Queensland , Australia ( Graves) ;</note>
								<orgName type="department">Graves)</orgName>
								<orgName type="institution">Queensland University of Technology</orgName>
								<address>
									<settlement>Queensland</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<note type="raw_affiliation">University of Auckland , Auckland , New Zealand (Whittaker) ;</note>
								<orgName type="department">Whittaker</orgName>
								<orgName type="institution">University of Auckland</orgName>
								<address>
									<settlement>Auckland</settlement>
									<country key="NZ">New Zealand</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<note type="raw_affiliation">University of Sydney , Sydney , Australia Cardiovascular Division ,</note>
								<orgName type="department">Cardiovascular Division</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<note type="raw_affiliation">The George Institute for Global Health , PO Box M201 , Missenden Road , Camperdown , NSW 2050 Australia</note>
								<orgName type="institution">The George Institute for Global Health</orgName>
								<address>
									<addrLine>Missenden Road</addrLine>
									<postBox>PO Box M201</postBox>
									<postCode>2050</postCode>
									<settlement>Camperdown</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_8267HXd">Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease A Randomized Clinical Trial</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-03-08">March 8, 2016.</date>
						</imprint>
					</monogr>
					<idno type="MD5">C22D46561377D4756DF50BADC20DAB38</idno>
					<idno type="DOI">10.1001/jama.2015.10945</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T10:42+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_4veGxfV"><p xml:id="_yhAdnCU"><s xml:id="_SKA5rBf">IMPORTANCE Cardiovascular disease prevention, including lifestyle modification, is important but underutilized.</s><s xml:id="_966UCHJ">Mobile health strategies could address this gap but lack evidence of therapeutic benefit.</s><s xml:id="_xkWk3Qm">OBJECTIVE To examine the effect of a lifestyle-focused semipersonalized support program delivered by mobile phone text message on cardiovascular risk factors.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_A4cRXFf">DESIGN AND SETTING</head><p xml:id="_HkffbJM"><s xml:id="_ePCJqFz">The Tobacco, Exercise and Diet Messages (TEXT ME) trial was a parallel-group, single-blind, randomized clinical trial that recruited 710 patients (mean age, 58 [SD, 9.2] years; 82% men; 53% current smokers) with proven coronary heart disease (prior myocardial infarction or proven angiographically) between September 2011 and November 2013 from a large tertiary hospital in Sydney, Australia.</s></p><p xml:id="_A2sxAX5"><s xml:id="_YYSrnrY">INTERVENTIONS Patients in the intervention group (n = 352) received 4 text messages per week for 6 months in addition to usual care.</s><s xml:id="_NJKuEma">Text messages provided advice, motivational reminders, and support to change lifestyle behaviors.</s><s xml:id="_Ru2Aqgf">Patients in the control group (n=358) received usual care.</s><s xml:id="_mqxzdY5">Messages for each participant were selected from a bank of messages according to baseline characteristics (eg, smoking) and delivered via an automated computerized message management system.</s><s xml:id="_a2sNt2g">The program was not interactive.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Kh3U8Zc">MAIN OUTCOMES AND MEASURES</head><p xml:id="_TnGtCGM"><s xml:id="_z3WUDU4">The primary end point was low-density lipoprotein cholesterol (LDL-C) level at 6 months.</s><s xml:id="_FYn9uUs">Secondary end points included systolic blood pressure, body mass index (BMI), physical activity, and smoking status.</s></p><p xml:id="_zB6sTPG"><s xml:id="_NBZ3JSy">RESULTS At 6 months, levels of LDL-C were significantly lower in intervention participants, with concurrent reductions in systolic blood pressure and BMI, significant increases in physical activity, and a significant reduction in smoking.</s><s xml:id="_Rx9dXgq">The majority reported the text messages to be useful (91%), easy to understand (97%), and appropriate in frequency (86%).</s><s xml:id="_6SeZvTA">Parameter Mean (95% CI) Mean Difference (95% CI) P Value Intervention Control LDL-C, mg/dL 79 (76 to 82) 84 (81 to 87) -5 (-9 to 0) .04</s><s xml:id="_h5dpkhc">Systolic blood pressure, mm Hg 128.2 (126.7 to 129.8) 135.8 (134.3 to 137.3) -7.6 (-9.8 to -5.4) &lt;.001 BMI 29.0 (28.8 to 29.3) 30.3 (30.1 to 30.5) -1.3 (-1.6 to -0.9) &lt;.001 Physical activity, MET min/wk 932 (825 to 1039) 587 (482 to 692) 345 (195 to 495) &lt;.001 Smoking, No./total (%) 88/339 (26.0) 152/354 (42.9)</s><s xml:id="_pDvpjaE">RR, 0.61 (0.48 to 0.76) &lt;.001</s></p><p xml:id="_y4eV69c"><s xml:id="_QB473gt">CONCLUSIONS AND RELEVANCE Among patients with coronary heart disease, the use of a lifestyle-focused text messaging service compared with usual care resulted in a modest improvement in LDL-C level and greater improvement in other cardiovascular disease risk factors.</s><s xml:id="_dFGAtYC">The duration of these effects and hence whether they result in improved clinical outcomes remain to be determined.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QPnMCHE">G</head><p xml:id="_y4Hgryq"><s xml:id="_ycm4GUZ">lobally, cardiovascular disease is the leading cause of death and disease burden. <ref type="bibr" target="#b0">1</ref> Many treatments and treatment strategies are proven to reduce the risk of major cardiovascular events.</s><s xml:id="_XgWJGG7">Interventions that modify lifestyle factors are among the most effective but are poorly adhered to. <ref type="bibr" target="#b1">2</ref> Secondary prevention is an effective way to reduce the burden of cardiovascular disease and is a current priority of the World Heart Federation.</s><s xml:id="_xzYSZRy">Currently there are large gaps in utilization of preventive drugs, <ref type="bibr" target="#b2">3</ref> control of risk factors, <ref type="bibr" target="#b3">4</ref> and uptake of lifestyle-changing behaviors. <ref type="bibr" target="#b1">2</ref></s><s xml:id="_GC9JBWE">This is often because of failure in the initiation of secondary prevention.</s></p><p xml:id="_XP6PuDf"><s xml:id="_TSbfCns">Cardiac rehabilitation programs deliver comprehensive support, education, and monitoring of patients after a cardiovascular event.</s><s xml:id="_KmttEJ5">In a meta-regression analysis of 63 randomized trials of 21 295 patients, formal secondary prevention programs were associated with lower mortality and recurrent myocardial infarction. <ref type="bibr" target="#b4">5</ref></s><s xml:id="_bDwkm4e">However, there is substantial underutilization of existing programs internationally, with at best one-third of patients participating in cardiac rehabilitation programs after an acute coronary syndrome event. <ref type="bibr" target="#b5">6</ref></s><s xml:id="_MPpsfxm">Barriers to use include distance to services and time pressures caused by the need for face-to-face in-hospital or clinical setting attendance.</s><s xml:id="_4wyycPh">There is therefore a need to develop simple, lowcost, widely available alternatives to improve the adoption of healthy lifestyles, particularly in patients at highest risk of cardiovascular events.</s><s xml:id="_dcpqeQv">Mobile phone text messages to remind, encourage, and motivate patients might be useful in this regard, but there has been limited robust scientific evaluation of these interventions.</s></p><p xml:id="_6jsJ74W"><s xml:id="_Snca9nG">This study aimed to evaluate, in a randomized clinical trial, the effect of a text message-based intervention to encourage lifestyle change on objective measures of cardiovascular risk in individuals with coronary heart disease (CHD).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_xFCJJdh">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_uhB9VpE">Study Design</head><p xml:id="_aSVxjqe"><s xml:id="_7x9Rccg">The Tobacco, Exercise and Diet Messages (TEXT ME) study was a parallel-design, single-blind, randomized clinical trial enrolling 710 patients with CHD (Figure). <ref type="bibr" target="#b6">7</ref></s><s xml:id="_4mABWPM">Recruiting personnel and clinicians were blinded to assignment.</s><s xml:id="_9VSdam2">Objective measures of cardiovascular risk factors (low-density lipoprotein cholesterol [LDL-C] level, blood pressure, body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], and self-reported measures of physical activity, diet, and medications) were obtained at baseline and 6 months postrandomization.</s><s xml:id="_zuZKec9">Demographic information, including education and ethnic origin, was obtained at baseline.</s><s xml:id="_2DvMvC8">Using an open-ended question, we asked each patient to report his or her own ethnic origin.</s><s xml:id="_n7wsgWZ">We recorded the patient's self-reported ethnicity, and the researcher later categorized these data into a fixed set of categories.</s></p><p xml:id="_PpG38Je"><s xml:id="_tQMHc6p">Patients provided written informed consent, and ethical approval was obtained from the Western Sydney Local Health Network Human Research Ethics Committee.</s><s xml:id="_7fHZvZx">The study protocol is available in Supplement 1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_tnk8H6K">Participants</head><p xml:id="_HEEvBjQ"><s xml:id="_b5qjzrs">Patients with CHD were recruited at a large tertiary referral center and university teaching hospital in Sydney, Australia.</s><s xml:id="_qjYPgwe">The site is a public hospital and serves the Western Sydney Local Health District, a densely populated, ethnically diverse population that contains areas with among the highest levels of socioeconomic disadvantage in Australia.</s><s xml:id="_7gGKBNs">Approximately 43% of district residents are born overseas, compared with 27% for the state, with South Asia (11.7%) and Other Asia (10.2%) the most common overseas regions of birth. <ref type="bibr" target="#b7">8</ref></s><s xml:id="_thZzFm6">Potential participants were identified through screening daily admissions, coronary angiogram case lists, and cardiology outpatient clinic lists.</s></p><p xml:id="_CuAN2m8"><s xml:id="_JSWHbFq">Patients were eligible if they were older than 18 years, had documented CHD, and were able to provide informed consent.</s><s xml:id="_qeavXGm">Patients were excluded if they did not have an active mobile phone or sufficient English language proficiency to read text messages.</s><s xml:id="_ExvkpfX">A log was kept of all participants screened.</s><s xml:id="_9gwZHbh">Patients referred for evaluation of congenital heart disease or coronary anomalies were excluded.</s><s xml:id="_KBuNTEH">CHD was defined as documented prior myocardial infarction, coronary artery bypass graft surgery, percutaneous coronary intervention, or 50% or greater stenosis in at least 1 major epicardial vessel on coronary angiography.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_WT2TAxC">Randomization</head><p xml:id="_uYmeHA4"><s xml:id="_nF9xttD">Randomization occurred via a computerized randomization program that was accessed through a secure web interface.</s><s xml:id="_KnBDvHa">The random allocation sequence was in a uniform 1:1 allocation ratio with a block size of 8 and was concealed from study personnel.</s><s xml:id="_dRPpj4g">Study staff enrolled patients by entering data into the secure web interface.</s><s xml:id="_jh2sy6U">The computerized randomization program interfaced with the message-sending program to trigger the sending of messages to patients randomized to the intervention.</s><s xml:id="_xGcHQ4X">To maintain blinding of study personnel, patients were informed of their allocation in a text message sent after hospital discharge.</s><s xml:id="_yjcJgny">Prior to their follow-up appointment patients also received a text message to ask them not to reveal their allocation status to study personnel or clinicians in follow-up visits.</s><s xml:id="_aDQdvM9">Intervention participants received, in addition to usual care, the 6-month prevention program of approximately 96 messages.</s><s xml:id="_wPcbUuQ">Control participants received usual care, which generally included community follow-up with the majority referred to inpatient cardiac rehabilitation, as determined by their usual physicians.</s><s xml:id="_p6YrVfA">Both groups received 3 study management text messages providing them with their allocation assignment, study contact details, and a reminder prior to the follow-up appointment.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_7xt9AAg">Intervention</head><p xml:id="_qKjTUsH"><s xml:id="_dbHT3Ju">The text message-based prevention program involved delivery of regular semipersonalized text messages (some messages personally addressed through a "mail-merge"-type function with the participant's preferred name) providing advice, motivation, and information that aimed to improve diet, increase physical activity, and encourage smoking cessation (if relevant).</s><s xml:id="_3RDDRTF">Content for each participant was selected using a prespecified algorithm dependent on key baseline characteristics.</s><s xml:id="_jxS2APK">Participants received 4 messages per week for 24 weeks.</s><s xml:id="_XrjaXm2">Each message was sent on 4 of 5 randomly selected weekdays and arrived at random times of the day during working hours.</s></p><p xml:id="_CaFyp2p"><s xml:id="_UangrvC">A bank of messages was developed with input from investigators, clinicians, academics, and patients through a multistage iterative process previously described in detail. <ref type="bibr" target="#b8">9</ref></s><s xml:id="_ppbWJbK">The content of messages was based on and referred to the Australian Heart Foundation Healthy Living Guidelines. <ref type="bibr" target="#b9">10</ref> Content was developed for 4 modules: smoking, diet, physical activity, and general cardiovascular health.</s><s xml:id="_ZrHYcuG">The general module of messages included information generally provided by secondary prevention programs, eg, on chest pain action plans, guidelines and risk factor targets, and medications and adherence.</s></p><p xml:id="_mZVRHJK"><s xml:id="_NtVw52t">The message management program selected messages for each participant at random from the bank of messages from all relevant content areas as per the prespecified algorithms and using baseline data entered into the message management system-eg, nonsmokers would not be sent smoking messages, and vegetarians would not be sent information about meat.</s><s xml:id="_PuC7Qva">Some messages were merged with patient's preferred names, eg, "Have you gone for your walk today Jane?"</s><s xml:id="_sdvQdZc">The Box provides other examples of messages.</s><s xml:id="_uAsCrac">The message management system, previously described in detail, <ref type="bibr" target="#b8">9</ref> sent messages to participants randomized to the intervention according to our prespecified algorithms on content, frequency, and timing described above.</s></p><p xml:id="_7FWevbx"><s xml:id="_yWFxckQ">At study entry all participants were given brief (average, 3 to 5 minutes) training, if necessary, on how to read a text message and how to delete or save messages.</s><s xml:id="_qqXTPaW">Participants were told not to respond to messages and informed that messages would be managed through a computerized messaging engine.</s><s xml:id="_chJeP6U">Responses to all messages were monitored by study staff, but interactive communication did not occur.</s><s xml:id="_Rt6uJtU">"Stop" messages were followed up by study staff to check if the participant wanted to stop the program.</s><s xml:id="_9P4u2Rh">This was needed to meet legal requirements for sending bulk text messages.</s></p><p xml:id="_PzK34Nx"><s xml:id="_U65xd28">We bought a bulk package of text messages from a local service provider to run the TEXT ME study.</s><s xml:id="_ht9FHMY">We used these costs to calculate an average cost for sending each text message.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dkRGjZJ">Trial Procedures</head><p xml:id="_DQTPkYU"><s xml:id="_PXvJWjw">All participants were assessed at baseline and followed up at 6 months with a clinic visit.</s><s xml:id="_HGbXjdY">Fasting lipids levels, blood pressure, heart rate, BMI, and waist circumference were measured according to international standardized procedures 11 at baseline and at 6 months.</s><s xml:id="_2GKskmC">Blood pressure and heart rate were measured using electronic devices (Omron IA2, Omron Healthcare Inc).</s><s xml:id="_3CrGD3S">Three resting, sitting measurements were taken, each at least 5 minutes apart, and the mean of the last 2 readings were used for analyses.</s><s xml:id="_kveXeQ5">Fasting blood samples were analyzed by local laboratories.</s><s xml:id="_AuAcR6b">Physical activity was assessed with the Global Physical Activity Questionnaire. <ref type="bibr" target="#b11">12</ref></s><s xml:id="_ssCbTXj">Medical history, self-Figure.</s><s xml:id="_kaUNsbK">Enrollment of Participants in the TEXT-ME Randomized Clinical Trial 319 Included in primary analysis 20 Excluded (missing LDL-C measures at baseline, 6 mo, or both) 333 Included in primary analysis 21 Excluded (missing LDL-C measures at baseline, 6 mo, or both) 352 Randomized to receive text message intervention (336 with LDL-C measures) 358 Randomized to receive usual care (348 with LDL-C measures) 341 Completed intervention 11 Did not complete intervention 7 Requested that messages be stopped 4 Died during intervention period 4 Did not like the messages 1 Comorbidities 1 Moved to another country 1 On holiday 358 Completed usual care 1301 Patients assessed for eligibility 591 Excluded 265 Did not own mobile phone 10 Baseline assessment not completed 205 Not proficient in English 70 Declined to participate 41 Other 710 Randomized 339 Assessed at 6-mo visit (332 with LDL-C measures) 13 Did not complete 6-mo assessment 9 Unable to contact 4 Died prior to 6-mo visit 354 Assessed at 6-mo visit (342 with LDL-C measures) 4 Did not complete 6-mo assessment 3 Unable to contact 1 Died prior to 6-mo visit LDL-C indicates low-density lipoprotein cholesterol.</s><s xml:id="_3HmNAbH">Lifestyle-Focused Text Messaging and Coronary Heart Disease Original Investigation Research jama.com (Reprinted) JAMA September 22/29, 2015 Volume 314, Number 12 1257</s></p><p xml:id="_CXgBeBg"><s xml:id="_acUZQ65">Copyright 2015 American Medical Association.</s><s xml:id="_FDDHvfj">All rights reserved.</s></p><p xml:id="_gnffCdd"><s xml:id="_utuCUAg">Downloaded from jamanetwork.com</s><s xml:id="_gFwyAuh">by University of Iowa user on 07/12/2025</s></p><p xml:id="_62QdwTE"><s xml:id="_ydvqypa">Copyright 2015 American Medical Association.</s><s xml:id="_2Be2E4g">All rights reserved.</s></p><p xml:id="_kSVzscw"><s xml:id="_hvGnvqE">reported portions of fruit and vegetables consumed in the prior 7 days, and medications prescribed were recorded.</s><s xml:id="_QpVvtXR">Current or prior smoking history was assessed through self-report and confirmed with a carbon monoxide meter breath analyzer (Micro Plus Smokerlyzer, Airmet Scientific). <ref type="bibr" target="#b12">13</ref></s><s xml:id="_uJn84cj">ntervention participants were also administered a separate questionnaire that assessed the acceptability and perceived utility of the intervention.</s><s xml:id="_jznXnxX">These were given or sent to participants by mail, fax, or email or obtained through telephone assessments that occurred after the final outcome assessment.</s><s xml:id="_ZVHePQm">They were not collected by the outcome assessor performing the follow-up assessment and were mainly collected by student volunteers.</s></p><p xml:id="_FYGp9gJ"><s xml:id="_VBm8ycu">In addition, screening logs, logs of the number of messages successfully delivered, and responses to text messages were kept.</s></p><p xml:id="_DVrWa96"><s xml:id="_SUMHMSY">The primary outcome of the study was level of plasma LDL-C at 6 months.</s><s xml:id="_5YtAQmr">The secondary outcomes were systolic blood pressure, BMI, total cholesterol level, waist circumference, heart rate, total physical activity, smoking status, and the proportion achieving guideline levels of modifiable risk factors 1 (LDL-C &lt;77 mg/dL [to convert LDL-C values to mmol/L, multiply by 0.0259], <ref type="bibr" target="#b13">14</ref> blood pressure &lt;140/90 mm Hg, <ref type="bibr" target="#b2">3</ref> exercising regularly [≥5 d/wk × 30 minutes of moderate exercise per session], 4 nonsmoker status, <ref type="bibr" target="#b4">5</ref> and BMI &lt;25). <ref type="bibr" target="#b14">15</ref></s><s xml:id="_Cg2g2Ar">We also prespecified in the statistical analysis plan and report the other efficacy variable of proportion achieving combined risk factor control (achieving risk factor targets in 4 or more of the 5 modifiable risk factors listed above) as a measure of a multiple risk factor effect.</s><s xml:id="_cknefwM">We also report the proportion of patients taking cardioprotective medications at follow-up (eTable in Supplement 2).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_gnV7Knw">Statistical Analysis</head><p xml:id="_fbAGFxA"><s xml:id="_dGUFavK">Prior to the study, <ref type="bibr" target="#b6">7</ref> we estimated that a sample size of 634, increasing to 704 to allow for a 10% loss to follow-up, would have 90% power (2-tailed and at a 5% significance level) to detect a difference of 10 mg/dL in LDL-C level (assuming a mean level of 114 mg/dL [SD, 37 mg/dL] in the control group). <ref type="bibr" target="#b15">16</ref></s><s xml:id="_bXsax3p">This sample size would have approximately 90% power to detect a 5-mm Hg difference in systolic blood pressure and a difference of 1.2 in BMI.</s></p><p xml:id="_nbb8334"><s xml:id="_hMDH5F3">We followed a prespecified statistical analysis plan (available in Supplement 1), and all intervention evaluations were performed on the principle of intention to treat.</s><s xml:id="_6fNzZWt">Participants were analyzed by original assigned groups.</s></p><p xml:id="_Fkmfuyf"><s xml:id="_yVJ3sMx">Our primary analysis used analysis of covariance (ANCOVA) with baseline values of the analyzed parameters used as covariates where appropriate.</s><s xml:id="_sSsJVBh">The analyses were otherwise unadjusted.</s><s xml:id="_pVjx5KY">Thus, for example, the plasma LDL-C level at month 6 was analyzed using ANCOVA with the baseline value of LDL-C as the covariate.</s><s xml:id="_zsSGFv4">The above method was also used for continuous secondary outcomes.</s><s xml:id="_6r6Fa4n">With respect to management of combined risk factors, the proportion of patients achieving at least 4 of the 5 target risk factors was analyzed in terms of relative risk at month 6 and compared between groups using a log-binomial regression.</s></p><p xml:id="_8pDHwu5"><s xml:id="_kB6t6pE">Summaries of continuous baseline variables are presented as means and standard deviations unless skewed and then presented as medians and interquartile ranges.</s><s xml:id="_Ba7mQwE">Categorical variables are presented as frequencies and percentages.</s><s xml:id="_4QcZX7Q">Prespecified subgroup analyses were conducted if there was evidence of a significant (P &lt; .05)</s><s xml:id="_DktrGz9">treatment effect for LDL-C level, systolic blood pressure, and BMI by age, sex, education, smoking status, LDL-C tertiles, and acute coronary syndrome vs stable CHD.</s></p><p xml:id="_7ZZecFd"><s xml:id="_PX4dkXh">Analyses were conducted using SAS version 9.3 (SAS Institute Inc).</s><s xml:id="_536dJmT">All statistical tests were 2-tailed, and a 5% significance threshold was maintained.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_d2RY2NT">Results</head><p xml:id="_qzjCyeP"><s xml:id="_zXxN7GC">Between September 2011 and November 2013, 1301 patients were approached; we enrolled and randomized 710, and 591 did not meet all eligibility criteria or refused to participate (Figure).</s><s xml:id="_AgBPw49">Recruitment closed when our study sample size was achieved.</s><s xml:id="_ckaacZm">At the end of the study, 12 patients were unable to be contacted, a further 5 had died, and LDL-C blood assays were available for 674 (94.9% of randomized patients).</s><s xml:id="_6JcqTk6">The median time to follow-up was 6.7 months in the control group and 7.0 months in the intervention group.</s><s xml:id="_ZGkVkBe">Mean age was 57.6 years, 82% were men, mean LDL-C level was 101 mg/dL, mean blood pressure was 129/83 mm Hg, and mean BMI was 29.7.</s><s xml:id="_BkSfagh">Baseline characteristics were similar between the groups (Table <ref type="table" target="#tab_1">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_GH9Gx3B">Effect on Objective Measures of Risk Factors</head><p xml:id="_e9AB8ap"><s xml:id="_Kaw4j5P">LDL-C level, systolic blood pressure, and BMI at 6-month follow-up were all significantly lower in the intervention group compared with the control group (difference in LDL-C level, -5 mg/dL [95% CI, -9 to 0]; difference in systolic blood pressure,</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_TEFE5g4">Box. Examples of Text Messages Used in the TEXT ME Randomized Clinical Trial</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dMeeMaC">Smoking</head><p xml:id="_paET8BK"><s xml:id="_MgyPESf">[NAME], try identifying the triggers that make you want a cigarette &amp; plan to avoid them.</s></p><p xml:id="_wTwwhcG"><s xml:id="_akdNkKf">[NAME], for many it may take several attempts to quit, so keep trying.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9sAEh3p">Diet</head><p xml:id="_Jpm9qU7"><s xml:id="_UfVGrA3">Did you know 90% of people don't eat the recommended daily intake of vegetables (5 serves a day)?</s></p><p xml:id="_VpeuCrz"><s xml:id="_3KGxxpG">Try avoiding adding salt to your foods by using other spices or herbs.</s><s xml:id="_av9r5GY">participants (28.0%) (P = .45).</s><s xml:id="_PvCVmEF">There were no differences in the proportion taking secondary prevention medications in the intervention vs the control groups (eTable in Supplement 2).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dM4tEfv">Process Measures</head><p xml:id="_YmTgNME"><s xml:id="_MbuwY2q">Among the 591 individuals with CHD screened but not randomized, the main reasons were that they were not proficient enough in English (205 [35%]) or that they did not own a mobile phone (265 [45%]) (Figure).</s></p><p xml:id="_7gnX4JQ"><s xml:id="_H6cwfHk">After randomization, 7 patients from the intervention group requested that text messages be stopped during the 6-month follow-up period.</s><s xml:id="_W7YW8aj">These 7 patients withdrew at varying times during the 6 months, receiving between 6 and 46 of the 96 messages sent to intervention participants; the reasons described for withdrawal are listed in the Figure .</s><s xml:id="_vZy8e6z">Eleven further patients from the intervention group sent back "Stop" messages but, when contacted, reported they were mistaken and wanted to continue the program.</s><s xml:id="_Z9BAeG2">In the control group, 8 patients sent "Stop" messages after the initial control group message asking to not receive further text messages.</s></p><p xml:id="_YGM8VNY"><s xml:id="_khfhbBu">The approximate average cost was US $0.10 per message.</s><s xml:id="_Mge2PV8">We used this to calculate an average cost of less than US $10 per participant for sending the total 96 messages in the 6-month program.</s></p><p xml:id="_VpdQHyX"><s xml:id="_mZNYf5s">Among the 352 intervention participants, 307 (87%) sent back or responded to feedback questionnaires.</s><s xml:id="_398EKXq">The large majority reported the text-message support program to be useful (91%), easy to understand (97%), and motivating with respect to diet (81%) and physical activity change (73%) (Table <ref type="table" target="#tab_4">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_fFFS3V4">Discussion</head><p xml:id="_MQNZgkG"><s xml:id="_unf2JKr">Our study found that a simple, low-cost automated program of semipersonalized mobile phone text messages supporting lifestyle change compared with usual care led to significant differences in LDL-C level, systolic blood pressure, and BMI in patients with CHD.</s><s xml:id="_EWWrTAV">Intervention participants were also substantially more likely to exercise regularly and become nonsmokers.</s><s xml:id="_x5mFDBZ">There was a high level of acceptability of the intervention, with an overwhelming number of participants in the intervention group perceiving the messages to be of use and the level of contact to be appropriate.</s></p><p xml:id="_ZT74VnP"><s xml:id="_ZhNmDaM">The risk factor difference between the groups for LDL-C level was small, less than 20% of what may be expected if comparing a statin with placebo. <ref type="bibr" target="#b16">17</ref></s><s xml:id="_26Qmbbd">However, the differences were larger for blood pressure (similar to standard blood pressurelowering therapy compared with placebo <ref type="bibr" target="#b17">18</ref> ) and larger for BMI and physical activity (comparable or greater than achieved in cardiac rehabilitation programs). <ref type="bibr" target="#b18">19</ref></s><s xml:id="_6umFFtU">he proportion of patients achieving multiple guideline target levels of risk factors were substantially higher in the intervention group vs the control group, with 62.7% achieving at least 3 of 5 guideline levels in the intervention group, compared with 33.6% in the control group; 28.9% achieving at least 4 guideline levels in the intervention group, compared with 10.3% in the control group; and 4.7% achieving all 5 guideline levels in the intervention group, compared with 1.8% in the control group.</s><s xml:id="_urdmgjF">For some risk factor changes, such as for smoking, the treatment effect was attributable to an improvement in the study group and no change in the control group.</s><s xml:id="_2EXMExc">For others, such as blood pressure, it was attributable to a worsening in the control group after hospital discharge, which was not seen in the intervention group.</s></p><p xml:id="_QRHkZjr"><s xml:id="_2Ngqpvb">In recent years mobile phone text message-based interventions have arisen as a potential means of modifying health behaviors. <ref type="bibr" target="#b19">20</ref></s><s xml:id="_MMqsk4S">Recent studies have evaluated the effectiveness of mobile phone text messaging to change individual health behaviors of smoking, weight loss, and physical activity to improve medical management of diabetes <ref type="bibr" target="#b20">21</ref> or adherence to medication. <ref type="bibr" target="#b21">22</ref></s><s xml:id="_TxKNxmW">Few, however, include objective outcome measures, and concerns have been raised about potential biases associated with self-reported outcomes.</s><s xml:id="_2vWymKv">Also, there is very little evidence on the effects of these interventions on multiple risk factors. <ref type="bibr" target="#b19">20</ref></s><s xml:id="_q4FGEGt">Reducing multiple risk factors concurrently, rather than targeting single factors, is likely to deliver greater reduction in events. <ref type="bibr" target="#b22">23</ref></s><s xml:id="_QZPvJbA">ext messages can be sent quickly at low cost (approximately US $10 for the 96 messages sent by our program over 6 months) and can be easily automated.</s><s xml:id="_JRPRZVe">Mobile phone interventions that focus on text messaging have particular value, because they do not require a smartphone and are agnostic to the mobile operating system.</s><s xml:id="_pVKJxtB">Furthermore, most people across all income groups own a mobile phone, so a text message-based intervention has the potential to have substantial population effects.</s><s xml:id="_f4bMaTf">A feature of e-health or mobile health interventions is the potential for scalability owing to affordability and ability to deliver personalized services.</s><s xml:id="_Uwus2kT">This is particularly the case in low-income countries, where mobile phone usage is already highly prevalent. <ref type="bibr" target="#b23">24</ref></s><s xml:id="_aXtwHrr">As such, e-health and mobile health have gained momentum worldwide as a platform for transforming how health care is delivered, but to date there have been minimal scientific data on effectiveness. <ref type="bibr" target="#b24">25</ref></s><s xml:id="_EMRs7wU">This study helps address this gap in evidence to show that delivery of secondary prevention programs is possible, effective, and acceptable.</s><s xml:id="_Y5MyK97">For clinicians, text messaging provides a simple, low-cost means of providing a support program and perceived continuation of their care beyond the hospital or clinic encounter.</s><s xml:id="_2kyNEfX">One possible way via which these interventions may work is through greater patient engagement; this needs further examination in future research studies.</s><s xml:id="_whY4MxE">To policy makers and publicly or privately run health systems, the potential for population health benefit is apparent, as the intervention is likely scalable at low cost, behaviorally appropriate, acceptable to the patient, and exerts effect on multiple risk factors.</s></p><p xml:id="_KzsUBta"><s xml:id="_WXtDnnk">Our findings are consistent with the existing evidence to support the effectiveness of mobile phone text messaging in changing individual health behaviors.</s><s xml:id="_VRQS6AK">A number of randomized clinical trials have demonstrated the effectiveness of mobile phone text messaging to promote smoking cessation, <ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b26">27</ref> and a number of small randomized clinical trials have shown improvements in weight loss, <ref type="bibr" target="#b27">28</ref> physical activity, <ref type="bibr" target="#b28">29</ref> adherence to asthma medication, <ref type="bibr" target="#b29">30</ref> glycemic control in diabetes, <ref type="bibr" target="#b20">21</ref> blood pressure lowering, <ref type="bibr" target="#b21">22</ref> and adherence to medication among people with human immunodeficiency virus infection <ref type="bibr" target="#b23">24</ref> or after liver transplantation. <ref type="bibr" target="#b9">10</ref></s><s xml:id="_zvMRTex">The important differences with our current study are that our study targets multiple risk factors rather than individual risk factors, the sample size is larger than those for all these studies except the smoking studies, and the follow-up time is longer than for all studies and similar to that of the studies of human immunodeficiency virus treatment.</s></p><p xml:id="_PPUxSar"><s xml:id="_GUqE3SQ">Our population had relatively high rates of participation in cardiac rehabilitation.</s><s xml:id="_nCqQKDm">Hence, our findings suggest that messaging programs like TEXT ME could complement other programs like cardiac rehabilitation programs and provide ongoing support.</s></p><p xml:id="_Ent5Q9y"><s xml:id="_5UQeuT4">This study has a number of limitations that need to be considered.</s><s xml:id="_H3zgnFn">First, the outcome was the difference in risk factor levels, and a large study would be required to determine the effect of this intervention on clinical outcomes.</s><s xml:id="_UUwJT2e">However, we can infer from a large body of literature that change in risk factors can affect future clinical outcomes if they are sustained.</s><s xml:id="_GU8mc6T">Second, the current study was conducted from a single large tertiary referral center hospital, and it is unclear whether the observed benefits are generalizable.</s><s xml:id="_9zJxzzr">For example it is possible, but not shown in this study, that the benefits might be even greater in less affluent and more remote communities, where traditional secondary prevention programs are more difficult to access.</s><s xml:id="_8eANEZx">These questions could be addressed in future research by conducting similar trials in different settings and conducting collaborative meta-analyses or conducting larger trials across multiple settings.</s></p><p xml:id="_6FQx4Sy"><s xml:id="_2XFZw7E">Third, we only delivered the messages in English, despite considerable ethnic diversity among the study participants, and one of the main reasons for exclusion was that potential participants were non-English-speaking. Fourth, some of the secondary outcomes are measured using self-report; in particular, physical activity is measured through a self-reported questionnaire.</s></p><p xml:id="_vr6wTZC"><s xml:id="_ktfppMM">Fifth, this study assessed only the costs of the text messages delivered in the program.</s><s xml:id="_fQqsrS3">Given the modest effect sizes, it is not possible to determine whether the intervention represents a good value until formal cost-effectiveness analysis is conducted.</s><s xml:id="_GPNGzKK">Sixth, the trial could not be completely blinded, and we did not assess the effectiveness of the blinding.</s><s xml:id="_DKEsVHj">We did, however, minimize the effects of potential biases (1) by ensuring that data collectors did not know the group allocation at the time of recruitment, because this was determined by the computerized texting program and delivered in the first message, sent after hospital discharge; (2) by minimizing unblinding at follow-up by sending a message to participants asking them not to disclose their group allocation; and (3) most importantly, by using objective measures as our primary and key secondary outcomes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mpTDzzY">Conclusions</head><p xml:id="_Uxp32GY"><s xml:id="_KDDYr6y">Among patients with CHD, the use of a lifestyle-focused text messaging service compared with usual care resulted in a modest improvement in LDL-C level and moderate improvements in blood pressure, BMI, and smoking status.</s><s xml:id="_JzvqMgz">The duration of these effects and hence whether they result in improved clinical outcomes remain to be determined.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_du2RQKW"><s xml:id="_t8jjyzb">Hi [NAME], don't forget physical activity is good for you!</s><s xml:id="_rw8uzup">It reduces your risk of diabetes, heart attack, stroke, and their complications.</s><s xml:id="_yw5gf8B">Walking is cheap.</s><s xml:id="_7Kv5jFu">It can be done almost anywhere.</s><s xml:id="_2FCvGs8">All you need is comfortable shoes &amp; clothing.</s><s xml:id="_6uEEJBc">Have you got a chest pain Action Plan [NAME]?</s><s xml:id="_vRQS6Wg">Find ideas at http://www.heartfoundation.org.au/Pages/default.aspx</s><s xml:id="_xz5xFXp">Studies show that stress, worry &amp; loneliness can increase the risk of heart disease.</s><s xml:id="_UuanRms">Please talk to a health professional if you need help.</s><s xml:id="_VptmvJr">Baseline Characteristics</s></p></div></figDesc><table><row><cell>Physical Activity</cell></row><row><cell>General Cardiovascular Information</cell></row></table><note xml:id="_Pe5g5s3"><p><s xml:id="_BV2VxPn">d Participants who reported exercising 5 or more days per week × Ն30 min/d of moderate exercise.</s><s xml:id="_qpjZ45P">e Key guideline levels are the 5 guidelines listed in Table 3. Lifestyle-Focused Text Messaging and Coronary Heart Disease Original Investigation Research jama.com (Reprinted) JAMA September 22/29, 2015 Volume 314, Number 12 Control of Modifiable Risk Factors Participants in the intervention group were more likely to control their blood pressure (relative risk [RR], 1.44 [95% CI, 1.29-1.61]),</s><s xml:id="_V9GQPMX">exercise regularly (RR, 2.39 [95% CI, 1.92-2.97]),</s><s xml:id="_2ZkJ3Pa">and [95% CI, 1.95-4.02]).</s><s xml:id="_XeFXcAK">With respect to cardiac rehabilitation, 151 of 337 intervention participants (44.8%) and 143 of 353 control participants (40.5%) (P = .25 for difference) reported attending structured cardiac rehabilitation before or during the trial.</s><s xml:id="_4myWFfp">Structured rehabilitation occurred during the trial for 106 of 337 intervention participants (31.5%) and 99 of 353 control</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p xml:id="_m2qV5cj"><s xml:id="_5X6pfxr">Other End Point Analyses: Achieving Guideline Levels of Risk Factors at 6 Months' Follow-up a</s></p></div></figDesc><table><row><cell></cell><cell>No./Total (%)</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Intervention</cell><cell>Control</cell><cell>Relative Risk</cell><cell>P Value for</cell></row><row><cell>Variable</cell><cell>(n = 352)</cell><cell>(n = 358)</cell><cell>(95% CI)</cell><cell>Difference</cell></row><row><cell>LDL-C &lt;77 mg/dL</cell><cell>168/332 (50.6)</cell><cell>158/342 (46.2)</cell><cell>1.10 (0.94-1.28)</cell><cell>.25</cell></row><row><cell>Blood pressure &lt;140/90 mm Hg</cell><cell>262/331 (79.2)</cell><cell>189/344 (54.9)</cell><cell>1.44 (1.29-1.61)</cell><cell>&lt;.001</cell></row><row><cell>Exercising regularly b</cell><cell>182/338 (53.8)</cell><cell>79/351 (22.5)</cell><cell>2.39 (1.92-2.97)</cell><cell>&lt;.001</cell></row><row><cell>Nonsmoker</cell><cell>253/339 (74.6)</cell><cell>198/354 (55.9)</cell><cell>1.33 (1.19-1.49)</cell><cell>&lt;.001</cell></row><row><cell>BMI &lt;25 c</cell><cell>81/335 (24.2)</cell><cell>69/349 (19.8)</cell><cell>1.22 (0.92-1.62)</cell><cell>.16</cell></row><row><cell>Key guideline levels d</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Achieving all 5</cell><cell>15/322 (4.7)</cell><cell>6/330 (1.8)</cell><cell>2.56 (1.01-6.52)</cell><cell>.05</cell></row><row><cell>Achieving ≥4</cell><cell>93/322 (28.9)</cell><cell>34/330 (10.3)</cell><cell>2.80 (1.95-4.02)</cell><cell>&lt;.001</cell></row><row><cell>Achieving ≥3</cell><cell>202/322 (62.7)</cell><cell>111/330 (33.6)</cell><cell>1.87 (1.57-2.22)</cell><cell>&lt;.001</cell></row><row><cell cols="2">Abbreviations: BMI, body mass index; LDL-C, low-density lipoprotein</cell><cell></cell><cell></cell><cell></cell></row><row><cell>cholesterol.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">a Log-binomial regression including randomized groups (intervention and</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">control) and corresponding baseline values as fixed effects.</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">b Participants who reported exercising 5 or more days per week × Ն30 min/d of</cell><cell></cell><cell></cell></row><row><cell>moderate exercise.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note xml:id="_hmHJZe6"><p>c Calculated as weight in kilograms divided by height in meters squared.d  </p><p><s xml:id="_nms8ezT">A patient who achieves all guideline levels would have a combined risk factor of 5; a patient achieving none of them would be at 0.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_zG5UCgX"><s xml:id="_2ScFtJS">Primary and Secondary End Point Analyses at 6 Months Follow-up a</s></p></div></figDesc><table><row><cell></cell><cell>Mean (95% CI)</cell><cell></cell><cell></cell><cell></cell><cell>Abbreviations: BMI, body mass index;</cell></row><row><cell>Parameter</cell><cell>Intervention (n = 352)</cell><cell>Control (n = 358)</cell><cell>Mean Difference (95% CI)</cell><cell>P Value for Difference</cell><cell>IQR, interquartile range; LDL-C, low-density lipoprotein cholesterol;</cell></row><row><cell>Primary end point</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>MET, metabolic equivalent task.</cell></row><row><cell>LDL-C, mg/dL</cell><cell>79 (76 to 82)</cell><cell>84 (81 to 87)</cell><cell>-5 (-9 to 0)</cell><cell>.04</cell><cell>SI conversion factors: To convert total cholesterol and HDL-C values to</cell></row><row><cell>Secondary end points</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>mmol/L, multiply by 0.0259;</cell></row><row><cell>Blood pressure,</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>triglyceride values to mmol/L,</cell></row><row><cell>mm Hg</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>multiply by 0.0113.</cell></row><row><cell>Systolic</cell><cell>128 (127 to 130)</cell><cell>136 (134 to 137)</cell><cell>-8 (-10 to -5)</cell><cell>&lt;.001</cell><cell>a Analysis of covariance including</cell></row><row><cell>Diastolic</cell><cell>81 (80 to 82)</cell><cell>84 (83 to 85)</cell><cell>-3 (-4 to -2)</cell><cell>&lt;.001</cell><cell>randomized groups (intervention</cell></row><row><cell>Heart rate, /min</cell><cell>67 (66 to 68)</cell><cell>69 (68 to 70)</cell><cell>-2 (-3 to -0.4)</cell><cell>.01</cell><cell>and control) and baseline value for continuous measures. The</cell></row><row><cell>BMI</cell><cell>29.0 (28.8 to 29.3)</cell><cell>30.3 (30.1 to 30.5)</cell><cell>-1.3 (-1.6 to -0.9)</cell><cell>&lt;.001</cell><cell>proportion of inactive patients</cell></row><row><cell cols="2">Waist circumference, cm 100.6 (99.5 to 101.7)</cell><cell>105.0 (103.9 to 106.1)</cell><cell>-4.4 (-6.0 to -2.8)</cell><cell>&lt;.001</cell><cell>between groups has been</cell></row><row><cell>Hip circumference, cm</cell><cell>101.7 (100.5 to 102.9)</cell><cell>106.4 (105.2 to 107.5)</cell><cell>-4.7 (-6.3 to -3.0)</cell><cell>&lt;.001</cell><cell>compared using a log-binomial regression including randomized</cell></row><row><cell>Cholesterol, mg/dL</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>groups (intervention and control)</cell></row><row><cell>Total</cell><cell>150 (146 to 154)</cell><cell>159 (156 to 163)</cell><cell>-9 (-15 to -4)</cell><cell>&lt;.001</cell><cell>and corresponding baseline total</cell></row><row><cell>HDL-C</cell><cell>43 (42 to 44)</cell><cell>44 (43 to 45)</cell><cell>-0.4 (-2 to 1)</cell><cell>.55</cell><cell>physical activity MET values as fixed effect. Similarly, the proportions of</cell></row><row><cell>Triglycerides</cell><cell>140 (132 to 148)</cell><cell>160 (151 to 168)</cell><cell>-20 (-31 to -8)</cell><cell>.001</cell><cell>current smokers have been</cell></row><row><cell>Total physical activity</cell><cell>932 (825 to 1039)</cell><cell>587 (482 to 692)</cell><cell>345 (195 to 495)</cell><cell>&lt;.001</cell><cell>compared between groups using a</cell></row><row><cell>(MET min/wk)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>log-binomial regression including</cell></row><row><cell>Inactive</cell><cell>126/338 (37.4)</cell><cell>241/351 (68.8)</cell><cell>0.55 (0.47 to 0.64) b</cell><cell>&lt;.001</cell><cell>randomized groups (intervention</cell></row><row><cell>(&lt;600 MET min/wk),</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>and control) as fixed effect and the</cell></row><row><cell>No. (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>number of cigarettes per day at</cell></row><row><cell>Current smoking,</cell><cell>88/339 (26.0)</cell><cell>152/354 (42.9)</cell><cell>0.61 (0.48 to 0.76) b</cell><cell>&lt;.001</cell><cell>baseline as an adjustment variable.</cell></row><row><cell>No. (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note xml:id="_7N3G7AR"><p><s xml:id="_2CqZsFj">b Reported as relative risk (95% CI).</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 4 .</head><label>4</label><figDesc><div><p xml:id="_eP5A4yh"><s xml:id="_E6Cr7gS">Utility and Perceived Acceptability of Text-Message Support Program by Intervention Participants a</s></p></div></figDesc><table><row><cell></cell><cell>No./Total (%)</cell></row><row><cell>Characteristic</cell><cell>(n = 307) b</cell></row><row><cell>Usefulness and understanding</cell><cell></cell></row><row><cell>Found messages useful</cell><cell>279 (91)</cell></row><row><cell>Messages were easy to understand</cell><cell>297 (97)</cell></row><row><cell>Influence on motivation and behavior change</cell><cell></cell></row><row><cell>Messages motivated change</cell><cell>237 (77)</cell></row><row><cell>Diet more healthy due to messages</cell><cell>249 (81)</cell></row><row><cell>Exercise increased due to messages</cell><cell>223 (73)</cell></row><row><cell>Messages reminded to take medicines</cell><cell>234 (76)</cell></row><row><cell>Message saving and sharing</cell><cell></cell></row><row><cell>Read at least three-fourths of messages</cell><cell>293 (96)</cell></row><row><cell>Saved messages</cell><cell>167 (54)</cell></row><row><cell>Shared messages with family, friends, and/or clinicians</cell><cell>169 (55)</cell></row><row><cell>Appropriate message characteristics</cell><cell></cell></row><row><cell>Message language</cell><cell>291 (95)</cell></row><row><cell>No. of messages per week</cell><cell>264 (86)</cell></row><row><cell>Program length (6 mo)</cell><cell>237 (77)</cell></row><row><cell>Time of day messages received</cell><cell>276 (90)</cell></row></table><note xml:id="_EFtMq8Z"><p><s xml:id="_ZAQGa3X">a Response options were "Strongly agree, Agree, Neutral, Disagree, Strongly disagree" for items 1, 2, 3, 4, 5, and 6.</s><s xml:id="_CYtnhTm">We report the proportion that agree and strongly agree.</s><s xml:id="_6yB8bYH">For item 7, participants were asked what percentage of messages they read and given 5 categories.</s><s xml:id="_KuewND9">The response options were "Yes, No" for items 8, 9, and 10.</s><s xml:id="_gVGbBqP">The response options were "Too casual, Casual, Appropriate, Formal, Too formal" for item 10, with similar categories for items 11, 12, and 13. b Response rate for this survey was 307 of 352 (87%).</s></p></note></figure>
		</body>
		<back>

			<div type="funding">
<div xml:id="_SJxMSPD"><p xml:id="_qjKP5pG"><s xml:id="_w8perAk"><rs type="person">Dr Santo</rs> is funded by a <rs type="funder">University of Sydney International</rs> <rs type="grantName">Postgraduate Research Scholarship</rs>.</s><s xml:id="_WTUW7Mv"><rs type="person">Dr Hackett</rs> is funded by a <rs type="funder">National Heart Foundation</rs> <rs type="grantName">Future Leader Fellowship</rs>, <rs type="grantNumber">Level 2</rs> (<rs type="grantNumber">100034</rs>: <rs type="grantNumber">2014-17</rs>).</s><s xml:id="_Wgf5WAS">Dr Jan is funded by an <rs type="funder">NHMRC</rs> <rs type="grantName">Senior Research Fellowship</rs>.</s></p><p xml:id="_pU6ATG9"><s xml:id="_VuaMRWT">Role of the Funders/Sponsors: None of the funders/sponsors had any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</s></p></div>
			</div>
			<div type="funding">
<div xml:id="_G6VyDBu"><p xml:id="_AfqkDBU"><s xml:id="_2gCQjpC">Study concept and design: <rs type="person">Chow</rs>, <rs type="person">Redfern</rs>, <rs type="person">Hillis</rs>, <rs type="person">Hackett</rs>, <rs type="person">Barry</rs>, <rs type="person">Whittaker</rs>, Thiagalingam.</s><s xml:id="_hzw6nS4">Acquisition, analysis, or interpretation of data: <rs type="person">Chow</rs>, <rs type="person">Redfern</rs>, <rs type="person">Hillis</rs>, <rs type="person">Thakkar</rs>, <rs type="person">Santo</rs>, <rs type="person">Hackett</rs>, <rs type="person">Jan</rs>, <rs type="person">Graves</rs>, <rs type="person">Keizer</rs>, <rs type="person">Barry</rs>, <rs type="person">Bompoint</rs>, <rs type="person">Stepien</rs>, <rs type="person">Rodgers</rs>, <rs type="person">Thiagalingam.</rs></s><s xml:id="_96DwrUg">Drafting of the manuscript: <rs type="person">Chow</rs>, <rs type="person">Redfern</rs>, <rs type="person">Rodgers</rs>, <rs type="person">Thiagalingam</rs>.</s><s xml:id="_ErGU35y">Critical revision of the manuscript for important intellectual content: All authors.</s><s xml:id="_yCssCuz">Statistical analysis: <rs type="person">Chow</rs>, Santo, <rs type="person">Bompoint</rs>, <rs type="person">Stepien</rs>, <rs type="person">Rodgers</rs>.</s><s xml:id="_xTQaRCR">Obtained funding: <rs type="person">Chow</rs>, <rs type="person">Redfern</rs>, <rs type="person">Hillis</rs>, <rs type="person">Hackett</rs>, <rs type="person">Jan.</rs> Administrative, technical, or material support: <rs type="person">Redfern</rs>, <rs type="person">Hillis</rs>, <rs type="person">Thakkar</rs>, <rs type="person">Santo</rs>, <rs type="person">Hackett</rs>, <rs type="person">Graves</rs>, <rs type="person">Keizer</rs>, <rs type="person">Barry</rs>, <rs type="person">Whittaker</rs>, <rs type="person">Thiagalingam</rs>.</s><s xml:id="_D3nuXCh">Study supervision: <rs type="person">Chow</rs>, <rs type="person">Redfern</rs>, <rs type="person">Jan</rs>, <rs type="person">Graves</rs>, <rs type="person">Rodgers</rs>, Thiagalingam.</s><s xml:id="_s6rTZUt">Funding/Support: This work was supported by peer-reviewed grants from the <rs type="funder">National Heart Foundation of Australia</rs> <rs type="grantName">Grant-in-Aid</rs> (<rs type="grantNumber">G10S5110</rs>) and a <rs type="grantName">BUPA Foundation Grant</rs>.</s><s xml:id="_BVrRBFR"><rs type="person">Dr Chow</rs> is funded by a <rs type="grantName">Career Development Fellowship</rs> cofunded by the <rs type="funder">National Health and Medical Research Council (NHMRC)</rs> (<rs type="grantNumber">1033478</rs>) and <rs type="funder">National Heart Foundation</rs> (<rs type="grantNumber">11S6016</rs>) and <rs type="funder">Sydney Medical Foundation Chapman Fellowship</rs>.</s><s xml:id="_8pNvFC2"><rs type="person">Dr Redfern</rs> is funded by an <rs type="funder">NHMRC</rs> <rs type="grantName">Career Development Fellowship</rs> (<rs type="grantNumber">1061793</rs>) cofunded with a <rs type="funder">National Heart Foundation</rs> <rs type="grantName">Future Fellowship</rs> (<rs type="grantNumber">G160523</rs>).</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_pS98Rum">
					<orgName type="grant-name">Postgraduate Research Scholarship</orgName>
				</org>
				<org type="funding" xml:id="_5bgZ8Ts">
					<idno type="grant-number">Level 2</idno>
					<orgName type="grant-name">Future Leader Fellowship</orgName>
				</org>
				<org type="funding" xml:id="_XJ35rh7">
					<idno type="grant-number">100034</idno>
				</org>
				<org type="funding" xml:id="_h483rFK">
					<idno type="grant-number">2014-17</idno>
					<orgName type="grant-name">Senior Research Fellowship</orgName>
				</org>
				<org type="funding" xml:id="_cJ6duEQ">
					<idno type="grant-number">G10S5110</idno>
					<orgName type="grant-name">Grant-in-Aid</orgName>
				</org>
				<org type="funding" xml:id="_sWzYjDn">
					<orgName type="grant-name">BUPA Foundation Grant</orgName>
				</org>
				<org type="funding" xml:id="_bytgFHw">
					<idno type="grant-number">1033478</idno>
					<orgName type="grant-name">Career Development Fellowship</orgName>
				</org>
				<org type="funding" xml:id="_7jWmQ4V">
					<idno type="grant-number">11S6016</idno>
				</org>
				<org type="funding" xml:id="_2gNrQxH">
					<idno type="grant-number">1061793</idno>
					<orgName type="grant-name">Career Development Fellowship</orgName>
				</org>
				<org type="funding" xml:id="_6pwJuPZ">
					<idno type="grant-number">G160523</idno>
					<orgName type="grant-name">Future Fellowship</orgName>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_kTeGw5c">ARTICLE INFORMATION</head><p xml:id="_p7rPdzk"><s xml:id="_bx7ymca">Correction: This article was corrected online on March 8, 2016, to correct errors in the text and tables.</s></p><p xml:id="_vNwx43Z"><s xml:id="_XXSfjYC">Article Contributions: Dr Chow and Ms Bompoint had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Yk6xU5B">Conflict of Interest</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_aBn6ZyS">Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010</title>
		<author>
			<persName><forename type="first">R</forename><surname>Lozano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Naghavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Foreman</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(14)61682-2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9HM4QZw">Lancet</title>
		<imprint>
			<biblScope unit="volume">381</biblScope>
			<biblScope unit="page" from="2095" to="2128" />
			<date type="published" when="2012">2013. 9867. 2012. 9859</date>
		</imprint>
	</monogr>
	<note>published correction appears in Lancet</note>
	<note type="raw_reference">Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet. 2012;380(9859): 2095-2128.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_EEGbQuW">Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jolly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rao-Melacini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Anand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yusuf</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.109.891523</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Tau6u3J">Circulation</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="750" to="758" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010;121(6):750-758.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_v5r2BB2">Prospective Urban Rural Epidemiology (PURE) Study Investigators. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey</title>
		<author>
			<persName><forename type="first">S</forename><surname>Yusuf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(11)61215-4</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kxpCjzB">Lancet</title>
		<imprint>
			<biblScope unit="volume">378</biblScope>
			<biblScope unit="page" from="1231" to="1243" />
			<date type="published" when="2011">2011. 9798</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yusuf S, Islam S, Chow CK, et al; Prospective Urban Rural Epidemiology (PURE) Study Investigators. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011;378(9798): 1231-1243.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_NWXprKP">Prospective Urban Rural Epidemiology) Study Investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Teo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rangarajan</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2013.184182</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RAtmnsa">JAMA</title>
		<imprint>
			<biblScope unit="volume">310</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="959" to="968" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chow CK, Teo KK, Rangarajan S, et al; PURE (Prospective Urban Rural Epidemiology) Study Investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959-968.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_J3Nf4mt">Meta-analysis: secondary prevention programs for patients with coronary artery disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hartling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vandermeer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Mcalister</surname></persName>
		</author>
		<idno type="DOI">10.7326/0003-4819-143-9-200511010-00010</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CUW6Amv">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="659" to="672" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005;143(9):659-672.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_ayUAyUJ">The rise and fall of cardiac rehabilitation in the United Kingdom since 1998</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Bethell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Lewin</surname></persName>
		</author>
		<idno type="DOI">10.1093/pubmed/fdl091</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UBuEkrH">J Public Health (Oxf)</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="57" to="61" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bethell HJ, Evans JA, Turner SC, Lewin RJ. The rise and fall of cardiac rehabilitation in the United Kingdom since 1998. J Public Health (Oxf). 2007;29 (1):57-61.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_quJXgvz">Design and rationale of the Tobacco, EXercise and dieT MEssages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2011-000606</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9ccWUjn">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">e000606</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chow CK, Redfern J, Thiagalingam A, et al. Design and rationale of the Tobacco, EXercise and dieT MEssages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open. 2012;2(1):e000606.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<idno type="DOI">10.52768/2691-7785/1144</idno>
		<title level="m" xml:id="_qufDejU">Western Sydney Local Health District. Epidemiological Profile of WSLHD Residents</title>
		<meeting><address><addrLine>Sydney, Australia</addrLine></address></meeting>
		<imprint>
			<publisher>Western Sydney Local Health District</publisher>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Western Sydney Local Health District. Epidemiological Profile of WSLHD Residents. Sydney, Australia: Western Sydney Local Health District; 2013.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_PP6nP4x">Development of a set of mobile phone text messages designed for prevention of recurrent cardiovascular events</title>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jan</surname></persName>
		</author>
		<idno type="DOI">10.1177/2047487312449416</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nAmgCUC">Eur J Prev Cardiol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="492" to="499" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Redfern J, Thiagalingam A, Jan S, et al. Development of a set of mobile phone text messages designed for prevention of recurrent cardiovascular events. Eur J Prev Cardiol. 2014;21 (4):492-499.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_vajmkWz">Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging</title>
		<author>
			<persName><forename type="first">T</forename><surname>Miloh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Annunziato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Arnon</surname></persName>
		</author>
		<idno type="DOI">10.1542/peds.2009-0415</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FDnsCXX">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="844" to="e850" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Miloh T, Annunziato R, Arnon R, et al. Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging. Pediatrics. 2009;124(5):e844-e850.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<title level="m" type="main" xml:id="_Y7mBhPA">Anthropometric Standardization Reference Manual</title>
		<author>
			<persName><forename type="first">Tgra</forename><surname>Lohman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Martorell</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1988">1988</date>
			<publisher>Human Kinetics</publisher>
			<pubPlace>Champaign, IL</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Lohman TGRA, Martorell R. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics; 1988.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<idno type="DOI">10.5114/hpc.2018.80229</idno>
		<ptr target="http://www.who.int/chp/steps/GPAQ/en/" />
		<title level="m" xml:id="_XpjS87u">Global Physical Activity Questionnaire (GPAQ) Analysis Guide</title>
		<imprint>
			<publisher>WHO website</publisher>
			<date type="published" when="2011-09-07">September 7, 2011. August 25, 2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organisation (WHO). Global Physical Activity Questionnaire (GPAQ) Analysis Guide. WHO website. http://www.who.int/chp /steps/GPAQ/en/. September 7, 2011. Accessed August 25, 2015.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_tq9PudX">Breath analysis to detect recent exposure to carbon monoxide</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Cunnington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hormbrey</surname></persName>
		</author>
		<idno type="DOI">10.1136/pmj.78.918.233</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_h2JsDe6">Postgrad Med J</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">918</biblScope>
			<biblScope unit="page" from="233" to="237" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cunnington AJ, Hormbrey P. Breath analysis to detect recent exposure to carbon monoxide. Postgrad Med J. 2002;78(918):233-237.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_TamDcWh">National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management-2005</title>
		<author>
			<persName><forename type="first">A</forename><surname>Tonkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Barter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Best</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.hlc.2005.10.010</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DPmmAuK">Heart Lung Circ</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="275" to="291" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>National Heart Foundation of Australia; Cardiac Society of Australia and New Zealand</note>
	<note type="raw_reference">Tonkin A, Barter P, Best J, et al; National Heart Foundation of Australia; Cardiac Society of Australia and New Zealand. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management-2005. Heart Lung Circ. 2005;14(4): 275-291.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<idno type="DOI">10.1016/j.hlc.2005.10.010</idno>
		<title level="m" xml:id="_pTm4Gz6">Reducing Risk in Heart Disease: An Expert Guide to Clinical Practice for Secondary Prevention of Coronary Heart Disease</title>
		<meeting><address><addrLine>Melbourne</addrLine></address></meeting>
		<imprint>
			<publisher>National Heart Foundation of Australia</publisher>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand. Reducing Risk in Heart Disease: An Expert Guide to Clinical Practice for Secondary Prevention of Coronary Heart Disease. Melbourne: National Heart Foundation of Australia; 2012.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_DTK9Td2">Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Vale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Jelinek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Best</surname></persName>
		</author>
		<idno type="DOI">10.1001/archinte.163.22.2775</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7r3upv9">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="2775" to="2783" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vale MJ, Jelinek MV, Best JD, et al; COACH Study Group. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease. Arch Intern Med. 2003;163(22):2775-2783.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_dcXAUeJ">Cholesterol Treatment Trialists&apos; (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials</title>
		<author>
			<persName><forename type="first">B</forename><surname>Mihaylova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Emberson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Blackwell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Xq88Kcb">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="page" from="581" to="590" />
			<date type="published" when="2012">2012. 9841</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mihaylova B, Emberson J, Blackwell L, et al; Cholesterol Treatment Trialists&apos; (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581-590.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_aBKu4Ph">Blood Pressure Lowering Treatment Trialists&apos; Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials</title>
		<author>
			<persName><forename type="first">B</forename><surname>Neal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Macmahon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Chapman</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(00)03307-9</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Eh3QTw2">Lancet</title>
		<imprint>
			<biblScope unit="volume">356</biblScope>
			<biblScope unit="page" from="1955" to="1964" />
			<date type="published" when="2000">2000. 9246</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Neal B, MacMahon S, Chapman N; Blood Pressure Lowering Treatment Trialists&apos; Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000;356(9246): 1955-1964.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_39cYMX5">Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network</title>
		<author>
			<persName><forename type="first">P</forename><surname>Giannuzzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Temporelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Marchioli</surname></persName>
		</author>
		<idno type="DOI">10.1001/archinte.168.20.2194</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YPa77Gz">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">168</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="2194" to="2204" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Giannuzzi P, Temporelli PL, Marchioli R, et al; GOSPEL Investigators. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med. 2008;168(20):2194-2204.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_smFDqk8">Behavior change interventions delivered by mobile telephone short-message service</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Fjeldsoe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Marshall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">D</forename><surname>Miller</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2008.09.040</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_F2Cq85E">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="165" to="173" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fjeldsoe BS, Marshall AL, Miller YD. Behavior change interventions delivered by mobile telephone short-message service. Am J Prev Med. 2009;36(2):165-173.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_AeRH5bY">A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Franklin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Waller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pagliari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Greene</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1464-5491.2006.01989.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_A2ZVgQW">Diabet Med</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1332" to="1338" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Franklin VL, Waller A, Pagliari C, Greene SA. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabet Med. 2006;23(12):1332-1338.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_TrZdqTS">Effectiveness of an intervention to provide information to patients with hypertension as short text messages and reminders sent to their mobile phone (HTA-Alert)</title>
		<author>
			<persName><forename type="first">Márquez</forename><surname>Contreras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>De La Figuera Von Wichmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Gil</forename><surname>Guillén</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ByjS6w9">Aten Primaria</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="399" to="405" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Márquez Contreras E, de la Figuera von Wichmann M, Gil Guillén V, et al. Effectiveness of an intervention to provide information to patients with hypertension as short text messages and reminders sent to their mobile phone (HTA-Alert)]. Aten Primaria. 2004;34(8):399-405.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_nQvUPeG">Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Pearson</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.cir.0000133427.35111.67</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jqTc8ZM">Circulation</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="issue">25</biblScope>
			<biblScope unit="page" from="3112" to="3121" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Smith SC, Jackson R, Pearson TA, et al. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation. 2004;109(25):3112-3121.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_KR8kQdj">Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Lester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ritvo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Mills</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(10)61997-6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nYSTmx9">Lancet</title>
		<imprint>
			<biblScope unit="volume">376</biblScope>
			<biblScope unit="page" from="1838" to="1845" />
			<date type="published" when="2010">2010. 9755</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376 (9755):1838-1845.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_5haDQzh">Personal health technology: a new era in cardiovascular disease prevention</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Franklin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Lavie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Arena</surname></persName>
		</author>
		<idno type="DOI">10.1080/00325481.2015.1015396</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EUPQmsw">Postgrad Med</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="150" to="158" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Franklin NC, Lavie CJ, Arena RA. Personal health technology: a new era in cardiovascular disease prevention. Postgrad Med. 2015;127(2):150- 158.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_dgZSnRJ">Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial</title>
		<author>
			<persName><forename type="first">C</forename><surname>Free</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Knight</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Robertson</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(11)60701-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RUUpWs2">Lancet</title>
		<imprint>
			<biblScope unit="volume">378</biblScope>
			<biblScope unit="page" from="49" to="55" />
			<date type="published" when="2011">2011. 9785</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Free C, Knight R, Robertson S, et al. Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial. Lancet. 2011;378(9785):49-55.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_G6tSZvB">Mobile phone-based interventions for smoking cessation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mcrobbie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bullen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Borland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gu</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd006611.pub3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EYQq8RT">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">6611</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Whittaker R, McRobbie H, Bullen C, Borland R, Rodgers A, Gu Y. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD006611.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_vctZPwX">A text message-based intervention for weight loss: randomized controlled trial</title>
		<author>
			<persName><forename type="first">K</forename><surname>Patrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Raab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Adams</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.1100</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dx5e6Vg">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">e1</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Patrick K, Raab F, Adams MA, et al. A text message-based intervention for weight loss: randomized controlled trial. J Med Internet Res. 2009;11(1):e1.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_mdEcaSS">Using internet and mobile phone technology to deliver an automated physical activity program: randomized controlled trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hurling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Catt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Boni</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.9.2.e7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fXphFCW">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">7</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hurling R, Catt M, Boni MD, et al. Using internet and mobile phone technology to deliver an automated physical activity program: randomized controlled trial. J Med Internet Res. 2007;9(2):e7.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_eeT3RZU">A text message programme designed to modify patients&apos; illness and treatment beliefs improves self-reported adherence to asthma preventer medication</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Petrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Broadbent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Weinman</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.2044-8287.2011.02033.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_amjVWbU">Br J Health Psychol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="74" to="84" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Petrie KJ, Perry K, Broadbent E, Weinman J. A text message programme designed to modify patients&apos; illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br J Health Psychol. 2012;17(1):74-84.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
